Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David B. Bylund is active.

Publication


Featured researches published by David B. Bylund.


xPharm: The Comprehensive Pharmacology Reference | 2008

Soybean Trypsin Inhibitor

S.J. Enna; David B. Bylund

Five trypsin and cu-chymotrypsin inhibitors which have low molecular weights (ranging from 6800 to 8600) and are present in soybean seeds of the Tracy variety have been isolated and purified, and single crystals which give x-ray diffraction data beyond 3-A spacings have been obtained from one of them. The trypsin inhibitor crystallizes in a monoclinic unit cell of symmetry P2, and dimensions a = 25.919(7) A, b = 43.23(l) A, c = 19.905(5) A, and j3 = 103.63(2)“. The asymmetric unit contains 1 molecule of molecular weight 6800. The crystal, which has been found to be unusually stable to x-radiation, has a solvent content of approximately 26% by volume.


xPharm: The Comprehensive Pharmacology Reference | 2008

2,4-Dinitrophenol

S.J. Enna; David B. Bylund

Basic information has been importedinto this record. If you have more information on this agent and would like tobe come an xPharm contributor, please contact us at [email protected].


xPharm: The Comprehensive Pharmacology Reference | 2008

Cytokine Response Modifier A

S.J. Enna; David B. Bylund

Basic information has been imported into this record.If you have more information on this agent and would like to become an xPharm contributor, please contact us at [email protected].


xPharm: The Comprehensive Pharmacology Reference | 2008

Low Density Lipoprotein Receptor Related Protein

S.J. Enna; David B. Bylund


xPharm: The Comprehensive Pharmacology Reference | 2008

Insulin-Like Growth Factor-2

S.J. Enna; David B. Bylund


xPharm: The Comprehensive Pharmacology Reference | 2008

Alpha 2 Antiplasmin

S.J. Enna; David B. Bylund


xPharm: The Comprehensive Pharmacology Reference | 2008

Reduced Nicotinamide Adenine Dinucleotide

S.J. Enna; David B. Bylund


xPharm: The Comprehensive Pharmacology Reference | 2008

Formyl met leu phe

S.J. Enna; David B. Bylund


xPharm: The Comprehensive Pharmacology Reference | 2008

Ac-YVAD-CHO

S.J. Enna; David B. Bylund


xPharm: The Comprehensive Pharmacology Reference | 2008

Z-VAD-FMK

S.J. Enna; David B. Bylund

Collaboration


Dive into the David B. Bylund's collaboration.

Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge